Literature DB >> 12657137

Histopathological findings in rabbits after experimental acute exposure to the Loxosceles intermedia (brown spider) venom.

Katia Zoghbi Ospedal1, Marcia Helena Appel, José Fillus Neto, Oldemir Carlos Mangili, Silvio Sanches Veiga, Waldemiro Gremski.   

Abstract

Loxoscelism, the term used to describe envenomation with brown spiders, is characterized by a dermonecrotic lesion at the bite site. In the present investigation we submitted albino rabbits to an acute experimental envenomation protocol using Loxosceles intermedia (brown spider) venom, with in order to determine the pathogenesic features of the lesion induced by this spider, which is the cause of several accidents throughout the world. Rabbits received intradermal injections of the venom and were monitored over the first 4 h, and then at 12 h and 1, 2 and 5 days after envenomation. Histological specimens from 3 rabbits per time point were collected from euthanized animals and processed for histological examination by light microscopy. Major findings observed during the first 4 h were oedema, haemorrhage, degeneration of blood vessel walls, plasma exudation, thrombosis, neutrophil accumulation in and around blood vessels with an intensive diapedesis, a diffuse collection of inflammatory cells (polymorphonuclear leucocytes) in the dermis, and subcutaneous muscular oedema. Over the following hours and up to 5 days after envenomation the changes progressed to massive neutrophil infiltration (with no other leucocytes) into the dermis and even into subcutaneous muscle tissue, destruction of blood vessels, thrombosis, haemorrhage, myonecrosis, and coagulative necrosis on the 5th day.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12657137      PMCID: PMC2517689          DOI: 10.1046/j.1365-2613.2002.00241.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  23 in total

1.  Persistent painful plaque due to a brown recluse spider bite.

Authors:  J A Yiannias; R K Winkelmann
Journal:  Cutis       Date:  1992-10

Review 2.  Loxoscelism.

Authors:  J M Futrell
Journal:  Am J Med Sci       Date:  1992-10       Impact factor: 2.378

3.  NORTH AMERICAN LOXOSCELISM. NECROTIC BITE OF THE BROWN RECLUSE SPIDER.

Authors:  C J DILLAHA; G T JANSEN; W M HONEYCUTT; C R HAYDEN
Journal:  JAMA       Date:  1964-04-06       Impact factor: 56.272

4.  Histological findings after brown recluse spider envenomation.

Authors:  D M Elston; J S Eggers; W E Schmidt; A B Storrow; R H Doe; D McGlasson; J R Fischer
Journal:  Am J Dermatopathol       Date:  2000-06       Impact factor: 1.533

5.  A child with spider bite and glomerulonephritis: a diagnostic challenge.

Authors:  J M Lung; S B Mallory
Journal:  Int J Dermatol       Date:  2000-04       Impact factor: 2.736

6.  Loxosceles spider venom induces the production of alpha and beta chemokines: implications for the pathogenesis of dermonecrotic arachnidism.

Authors:  H F Gomez; M J Miller; A Desai; J S Warren
Journal:  Inflammation       Date:  1999-06       Impact factor: 4.092

7.  Oligosaccharide residues of Loxosceles intermedia (brown spider) venom proteins: dependence on glycosylation for dermonecrotic activity.

Authors:  S S Veiga; W Gremski; V L dos Santos; L Feitosa; O C Mangili; H B Nader; C P Dietrich; R R Brentani
Journal:  Toxicon       Date:  1999-04       Impact factor: 3.033

8.  Detection and characterization of metalloproteinases with gelatinolytic, fibronectinolytic and fibrinogenolytic activities in brown spider (Loxosceles intermedia) venom.

Authors:  L Feitosa; W Gremski; S S Veiga; M C Elias; E Graner; O C Mangili; R R Brentani
Journal:  Toxicon       Date:  1998-07       Impact factor: 3.033

9.  Dermonecrotic and lethal components of Loxosceles gaucho spider venom.

Authors:  K C Barbaro; J L Cardoso; V R Eickstedt; I Mota
Journal:  Toxicon       Date:  1992-03       Impact factor: 3.033

10.  The necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation. Differential induction of GM-CSF, IL-8, and E-selectin expression.

Authors:  K D Patel; V Modur; G A Zimmerman; S M Prescott; T M McIntyre
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more
  10 in total

1.  Identification, cloning, expression and functional characterization of an astacin-like metalloprotease toxin from Loxosceles intermedia (brown spider) venom.

Authors:  Rafael B da Silveira; Ana C M Wille; Olga M Chaim; Marcia H Appel; Dilza T Silva; Célia R C Franco; Leny Toma; Oldemir C Mangili; Waldemiro Gremski; Carl P Dietrich; Helena B Nader; Silvio S Veiga
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

2.  A novel hyaluronidase from brown spider (Loxosceles intermedia) venom (Dietrich's Hyaluronidase): from cloning to functional characterization.

Authors:  Valéria Pereira Ferrer; Thiago Lopes de Mari; Luiza Helena Gremski; Dilza Trevisan Silva; Rafael Bertoni da Silveira; Waldemiro Gremski; Olga Meiri Chaim; Andrea Senff-Ribeiro; Helena Bonciani Nader; Silvio Sanches Veiga
Journal:  PLoS Negl Trop Dis       Date:  2013-05-02

3.  Loxosceles gaucho venom-induced acute kidney injury--in vivo and in vitro studies.

Authors:  Rui V Lucato; Regina C R M Abdulkader; Katia C Barbaro; Glória E Mendes; Isac Castro; Maria A S F Baptista; Patrícia M Cury; Denise M C Malheiros; Nestor Schor; Luis Yu; Emmanuel A Burdmann
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

4.  Phospholipase D from Loxosceles laeta Spider Venom Induces IL-6, IL-8, CXCL1/GRO-α, and CCL2/MCP-1 Production in Human Skin Fibroblasts and Stimulates Monocytes Migration.

Authors:  José M Rojas; Tomás Arán-Sekul; Emmanuel Cortés; Romina Jaldín; Kely Ordenes; Patricio R Orrego; Jorge González; Jorge E Araya; Alejandro Catalán
Journal:  Toxins (Basel)       Date:  2017-04-05       Impact factor: 4.546

Review 5.  Biotechnological potential of Phospholipase D for Loxosceles antivenom development.

Authors:  Matías Fingermann; Adolfo Rafael de Roodt; Osvaldo Cascone; María Victoria Miranda
Journal:  Toxicon X       Date:  2020-04-18

Review 6.  Brown Spider (Loxosceles) Venom Toxins as Potential Biotools for the Development of Novel Therapeutics.

Authors:  Daniele Chaves-Moreira; Fernando Hitomi Matsubara; Zelinda Schemczssen-Graeff; Elidiana De Bona; Vanessa Ribeiro Heidemann; Clara Guerra-Duarte; Luiza Helena Gremski; Carlos Chávez-Olórtegui; Andrea Senff-Ribeiro; Olga Meiri Chaim; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2019-06-19       Impact factor: 4.546

Review 7.  Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.

Authors:  Luiza Helena Gremski; Fernando Hitomi Matsubara; Nayanne Louise Costacurta Polli; Bruno Cesar Antunes; Pedro Henrique de Caires Schluga; Hanna Câmara da Justa; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Front Mol Biosci       Date:  2021-06-17

8.  Isolation, N-glycosylations and Function of a Hyaluronidase-Like Enzyme from the Venom of the Spider Cupiennius salei.

Authors:  Olivier Biner; Christian Trachsel; Aline Moser; Lukas Kopp; Nicolas Langenegger; Urs Kämpfer; Christoph von Ballmoos; Wolfgang Nentwig; Stefan Schürch; Johann Schaller; Lucia Kuhn-Nentwig
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

Review 9.  Forty Years of the Description of Brown Spider Venom Phospholipases-D.

Authors:  Luiza Helena Gremski; Hanna Câmara da Justa; Thaís Pereira da Silva; Nayanne Louise Costacurta Polli; Bruno César Antunes; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2020-03-06       Impact factor: 4.546

10.  Toxicological Characterization and Phospholipase D Activity of the Venom of the Spider Sicarius thomisoides.

Authors:  Tomás Arán-Sekul; Ivanka Perčić-Sarmiento; Verónica Valencia; Nelly Olivero; José M Rojas; Jorge E Araya; Andrés Taucare-Ríos; Alejandro Catalán
Journal:  Toxins (Basel)       Date:  2020-11-06       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.